data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Zelira Therapeutics
(OTCQB:ZLDAF)
$0.72
0.0409[6.02%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$0.0161
-0.7039[-97.76%]
After Hours: 9:20AM EDT
Day Range0.71 - 0.7252 Wk Range- - 2.53Open / Close0.71 / 0.72Float / Outstanding- / 9.6M
Vol / Avg.0.5K / 0.3KMkt Cap6.9MP/E-50d Avg. Price0.14
Div / Yield-Payout Ratio-Total Float-EPS-

Zelira Therapeutics Stock (OTC:ZLDAF), Quotes and News Summary

Zelira Therapeutics Stock (OTC: ZLDAF) stock price, news, charts, stock research, profile.

Day Range0.71 - 0.7252 Wk Range- - 2.53Open / Close0.71 / 0.72Float / Outstanding- / 9.6M
Vol / Avg.0.5K / 0.3KMkt Cap6.9MP/E-50d Avg. Price0.14
Div / Yield-Payout Ratio-Total Float-EPS-
Vuk Zdinjak - Jul 22, 2022, 8:28AM
Maureen Meehan - Jun 9, 2022, 12:58PM
Benzinga Cannabis - Feb 28, 2022, 3:48PM
Javier Hasse - Feb 28, 2022, 2:05PM
Benzinga Cannabis Contributors - Dec 30, 2021, 3:17PM
Natan Ponieman - Sep 21, 2021, 5:48PM
PRNewswire - Sep 20, 2022, 8:38AM
PRNewswire - Jul 21, 2022, 12:42PM
Globe Newswire - Feb 24, 2022, 2:09AM
Globe Newswire - Jan 31, 2022, 2:09AM
Globe Newswire - Jan 12, 2022, 2:21AM
Globe Newswire - Dec 23, 2021, 12:51PM
There is no Press for this Ticker
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.
Read More
Q

How do I buy Zelira Therapeutics (ZLDAF) stock?

A

You can purchase shares of Zelira Therapeutics (OTCQB: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zelira Therapeutics's (ZLDAF) competitors?

A

There are no as such competitors for Zelira Therapeutics.

Q

What is the target price for Zelira Therapeutics (ZLDAF) stock?

A

There is no analysis for Zelira Therapeutics

Q

Current Stock Price for Zelira Therapeutics (ZLDAF)?

A

The stock price for Zelira Therapeutics (OTCQB: ZLDAF) is $0.72 last updated December 2, 2022, 7:06 PM UTC.

Q

Does Zelira Therapeutics (ZLDAF) pay a dividend?

A

There are no upcoming dividends for Zelira Therapeutics.

Q

When is Zelira Therapeutics (OTCQB:ZLDAF) reporting earnings?

A

Zelira Therapeutics does not have any upcoming earnings scheduled.

Q

Is Zelira Therapeutics (ZLDAF) going to split?

A

There is no upcoming split for Zelira Therapeutics.

Q

What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

A

Zelira Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.